- D70.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D70.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D70.2 – other international versions of ICD-10 D70.2 may differ.
ICD-10-CM D70.2 is grouped within Diagnostic Related Group(s):
- 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
- 809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
- 810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D70.2:
- drug-induced > Agranulocytosis (chronic) (cyclical) (genetic) (infantile) (periodic) (pernicious) D70.9
- drug-induced > secondary D70.4
- drug induced NEC > Leukopenia D72.819
- drug-induced > Neutropenia, neutropenic (chronic) (genetic) (idiopathic) (immune) (infantile) (malignant) (pernicious) (splenic) D70.9
- drug-induced > secondary (cyclic) (periodic) (splenic) D70.4